In a report released today, Steven Mah from TD Cowen reiterated a Buy rating on Rapid Micro Biosystems (RPID – Research Report). The company’s shares opened today at $1.03.
According to TipRanks, Mah is an analyst with an average return of -18.9% and a 20.56% success rate. Mah covers the Healthcare sector, focusing on stocks such as BioLife Solutions, AbCellera Biologics, and Ginkgo Bioworks Holdings.
Currently, the analyst consensus on Rapid Micro Biosystems is a Moderate Buy with an average price target of $2.75.
See today’s best-performing stocks on TipRanks >>
RPID market cap is currently $42.33M and has a P/E ratio of -0.71.
Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of RPID in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Rapid Micro Biosystems (RPID) Company Description:
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company’s flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
Read More on RPID:
- Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
- RPID Earnings this Week: How Will it Perform?
- Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
- Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4
- Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase
